OEM/ODM Manufacturer Corn starch biodegradable 8 inch fork to Sao Paulo Manufacturers
OEM/ODM Manufacturer Corn starch biodegradable 8 inch fork to Sao Paulo Manufacturers Detail:
The main raw material ingredient extracted from oil and oil resources have been increasingly scarce, all materials are extracted from the oil burning of non-biodegradable will pollute the environment.
The main using starch as raw materials, starch extracted from plants, belonging to the renewable resources is a return to natural environmental degradation products.
Our Biobased cultery:
Our biobased cutlery,”plant-starch” cultery is excellent for hot foods with a heat tolerance up to 110 centigrade.
Compared traditional cutlery made from 100% virgin plastics, this cutlery is made with 70% renewable material,which is a alternative choice.
Our biobased cutlery made from 70% renewable resources, although it is not compostable,but biobased and biodegradable.
The temperature tolerance between -10 to 110 centigrade. Microwave, fridge, freezer and oven friendly.
It is healthy, hygienic, nontoxic, harmless and safty.
Ecogreen has strong research capability and can deal with a bulk quantity purchase order and customized products.
Welcome to contact with us for more details.
Product detail pictures:
We depend on sturdy technical force and continually create sophisticated technologies to fulfill the demand of OEM/ODM Manufacturer Corn starch biodegradable 8 inch fork to Sao Paulo Manufacturers, The product will supply to all over the world, such as: The Swiss , Benin , Paraguay , As a way to use the resource on the expanding info in international trade, we welcome prospects from everywhere on the web and offline. In spite on the high quality goods we provide, effective and satisfying consultation service is supplied by our qualified after-sale service group. Item lists and detailed parameters and any other info weil be sent for you timely for the inquiries. So you should make contact with us by sending us emails or call us when you've got any questions about our organization. ou could also get our address information from our site and come to our enterprise. We get a field survey of our merchandise. We're confident that we'll share mutual accomplishment and create solid co-operation relations with our companions within this market place. We're seeking forward for your inquiries.
A team of researchers from Boston Children’s Hospital, Brigham and Women’s Hospital (BWH), and the Massachusetts Institute of Technology (MIT; all in Boston, MA) has developed a bio-inspired, ultraviolet (UV) light-activated adhesive that could rapidly attach biodegradable patches inside a beating heart–in the exact place where congenital holes in the heart occur, such as with ventricular heart defects.
When a child is born with a heart defect such as a hole in the heart, highly invasive therapies are challenging due to an inability to quickly and safely secure devices inside the heart. Sutures take too much time to stitch and can cause stress on fragile heart tissue, and currently available clinical adhesives are either too toxic or tend to lose their sticking power in the presence of blood or under dynamic conditions, such as in a beating heart.
“About 40,000 babies are born with congenital heart defects in the United States annually, and those that require treatment are plagued with multiple surgeries to deliver or replace non-degradable implants that do not grow with young patients,” says Jeffrey Karp, Ph.D., Division of Biomedical Engineering, BWH Department of Medicine, and co-senior study author.
Recognizing that many creatures in nature have secretions that are viscous and repel water, enabling them to attach under wet and dynamic conditions, the researchers developed a material with these properties that also is biodegradable, elastic, and biocompatible. According to the study authors, the degradable patches secured with the glue remained attached even at increased heart rates and blood pressure.
“This adhesive platform addresses all of the drawbacks of previous systems in that it works in the presence of blood and moving structures,” says Pedro del Nido, MD, Chief of Cardiac Surgery, Boston Children’s Hospital, co-senior study author. “It should provide the physician with a completely new, much simpler technology and a new paradigm for tissue reconstruction to improve the quality of life of patients following surgical procedures.”
Unlike current surgical adhesives, this new adhesive maintains very strong sticking power when in the presence of blood, and even in active environments.
“This study demonstrated that the adhesive was strong enough to hold tissue and patches onto the heart equivalent to suturing,” says the study’s co-first author Nora Lang, MD, Department of Cardiac Surgery, Boston Children’s Hospital. “Also, the adhesive patch is biodegradable and biocompatible, so nothing foreign or toxic stays in the bodies of these patients.”
Importantly, its adhesive abilities are activated with UV light, providing an on-demand, anti-bleeding seal within five seconds of UV light application when applied to high-pressure large blood vessels and cardiac wall defects.
“When we attached patches coated with our adhesive to the walls of a beating heart, the patches remained despite the high pressures of blood flowing through the heart and blood vessels,” says Maria N. Pereira, PhD, Division of Biomedical Engineering, BWH Department of Medicine, co-first study author.
The researchers note that their waterproof, light-activated adhesive will be useful in reducing the invasiveness of surgical procedures, as well as operating times, in addition to improving heart surgery outcomes.
The adhesive technology (and other related platforms) has been licensed to a start-up company, Gecko Biomedical (Paris, France). The company has raised $10.8 million (â‚¬8 million) in their recently announced Series A financing round and expects to bring the adhesive to the market within two to three years.
Full details of the study appear in Science Translational Medicine; for more information, please visit http://stm.sciencemag.org/content/6/218/218ra6.
patent foramen ovale
Atrial septal defect
By Ryan 2016-10-01 11:44
The factory workers have rich industry knowledge and operational experience, we learned a lot in working with them,we are extremely grateful that we can encount a good company has excellent wokers.
By Alan 2016-4-22 13:49